SCHEMBL12337063

SCHEMBL12337063

COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@@]1(I)c2c(cc3c(c2CO)OCO3)CCN1C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 7/20 0.55
CYP2C9 P11712 4/20 0.55
CYP2C19 P33261 4/20 0.55
TUBB4A P04350 4/20 0.55
TUBB P07437 4/20 0.55
TUBB4B P68371 4/20 0.55
TUBB3 Q13509 4/20 0.55
TUBB2A Q13885 4/20 0.55
TUBB8 Q3ZCM7 4/20 0.55
TUBB6 Q9BUF5 4/20 0.55
TUBB2B Q9BVA1 4/20 0.55
TUBB1 Q9H4B7 4/20 0.55
TUBA3C P0DPH7 3/20 0.55
TUBA1B P68363 3/20 0.55
TUBA4A P68366 3/20 0.55
TUBA3E Q6PEY2 3/20 0.55
TUBA1A Q71U36 3/20 0.55
TUBA1C Q9BQE3 3/20 0.55
ABCB11 O95342 2/20 0.55
CYP1A2 P05177 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13394635 0.91 CYP3A4 (0.61) CYP3A4CYP2C9CYP2C19TUBB4ATUBB
SCHEMBL7607290 0.85 TUBB4A (0.63) CYP3A4CYP2C9CYP2C19TUBB4ATUBB
SCHEMBL12337064 0.84 TUBB4A (0.56) CYP3A4CYP2C9CYP2C19TUBB4ATUBB
SCHEMBL682464 0.79 CYP3A4 (0.81) CYP3A4CYP2C9CYP2C19TUBB4ATUBB
SCHEMBL12145856 0.73 CYP3A4 (0.82) CYP3A4CYP2C9CYP2C19TUBB4ATUBB
SCHEMBL10073426 0.72 CYP3A4 (0.70) CYP3A4CYP2C9CYP2C19TUBB4ATUBB
SCHEMBL682243 0.72 CYP3A4 (0.70) CYP3A4CYP2C9CYP2C19TUBB4ATUBB
Noscapine SCHEMBL10307295 0.71 CYP3A4 (1.00) CYP3A4CYP2C9CYP2C19TUBB4ATUBB
Noscapine SCHEMBL14400084 0.71 CYP3A4 (1.00) CYP3A4CYP2C9CYP2C19TUBB4ATUBB
Noscapine SCHEMBL2494164 0.71 CYP3A4 (1.00) CYP3A4CYP2C9CYP2C19TUBB4ATUBB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011109237-A2 USES OF NOSCAPINE AND DERIVATIVES IN SUBJECTS DIAGNOSED WITH FAP EMORY UNIVERSITY (US) 2011-09-09 WO disclosed